The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Background: Access to essential medications is critical for an equitable healthcare system, yet the absence of a Uniform National Formulary (UNF) in the U.S. has led to disparities in drug affordability and access.

Authors

Publication Details

Journal
Journal of Health Statistics Reports
Published
2025-09-01
DOI
https://doi.org/10.47363/jhsr/2025(4)130
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Vishwanauth Persaud
Journal of Health Statistics Reports
Pharmaceutical Economics and Policy
article

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator

Vishwanauth Persaud
article en

Abstract

Background: Access to essential medications is critical for an equitable healthcare system, yet the absence of a Uniform National Formulary (UNF) in the U.S. has led to disparities in drug affordability and access.

Journal of Health Statistics ReportsVol. 4(3)
Openalex Percentile: Top 69%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Economic and Health Policy Impact of a Uniform National Formulary: Equity and Policy Considerations in the U.S. Using Cystic Fibrosis Treatment with Trikafta as a Cross-Comparator — Vishwanauth Persaud · Journal of Health Statistics Reports (2025) | TGRS Research Map | TGRS